Health and Healthcare

All Health and Healthcare Articles

Newest first · Page 376

Thursday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com Biotechnology GENETIC TECH SPON +48.22% DENDREON CORP +19.69% CORCEPT THERAPEUTICS +15.70% ANTIGENICS INC +14.83% REXAHN PHARMACEUTICL +14.29% Diagnostic Substances BIOSITE INC +10.45% HEALTHCARE TECH LTD +9.46% IMMUCOR INC +9.15% SYNOVICS…

Douglas A. McIntyre · 19 years ago

Wednesday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com Biotechnology IDM PHARMA INC +45.33% NANOGEN INC +30.95% ENCYSIVE PHARMA +14.89% CARDIOVASCULAR BIOTH +12.80% CYTRX CP +12.69% Diagnostic Substances HEALTHCARE TECH LTD +17.46% ASPENBIO PHARMA INC +8.24% PRESSURE BIOSCIENC +7.37%…

Douglas A. McIntyre · 19 years ago

Jim Cramer on Dendreon (DNDN)

Cramer in a question from a student tonight on CNBC’s MAD MONEY was actually asked about the recently wild Dendreon (DNDN-NASDAQ).  What he said was that he thinks it can still go up and…

Douglas A. McIntyre · 19 years ago

Biotech Implosion: ICAgen (ICGN)

ICAgen’s (ICGN-NASDAQ) stock is being crushed in after-hours trading, although the trading volume is very light.  Shares are down 37% to $1.15 after closing down 2.6% today.  Read on, because this one sounds in…

Douglas A. McIntyre · 19 years ago

Monday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com Biotechnology STEMCELLS INC +18.25% NOVAVAX INC +17.76% POLYMEDIX INC +15.79% IDM PHARMA INC +15.15% AASTROM BIOSCIENCE +13.77% Diagnostic Substances ICAGEN, INC. +17.39% REMOTEMDX INC +6.54% EPICEPT CORPORATION +5.20% AMER BIO…

Douglas A. McIntyre · 19 years ago

Stem Cell Stocks Gain On British Study, Geron Gives Some Back

by H.S. AyoubBioHealth Investor Scientists in Britain announced that a new heart-like muscle mass, complete with blood vessels and various types of cells, was grown from stem cells harvested from bone marrow. The lead…

Douglas A. McIntyre · 19 years ago

Other Biotech Stocks Chasing Dendreon Pre-Market

This shouldn’t be any shocker now, but the small-cap biotech stocks are getting attention this morning.  Of particular interest are the ones with clinical development programs for prostate and other cancers.  When you get…

Douglas A. McIntyre · 19 years ago

Dendreon Massive Pre-Market

Dendreon (DNDN-NASDAQ) won big yesterday after receiving panel backing from the FDA for Provenge for the treatment  of advanced prostate cancer.  The stock has reopened for trading just a few minutes ago and the…

Douglas A. McIntyre · 19 years ago

The Rising Cost of Healthcare Taken To Another Extreme

By Chad Brand of Peridot Capitalist LOS ANGELES, March 26 (Reuters) – Shares of Alexion Pharmaceuticals Inc. (ALXN) rose more than 9 percent on Monday after the company told analysts that its treatment for…

Douglas A. McIntyre · 19 years ago